608 related articles for article (PubMed ID: 28980194)
1. Gene Editing and Human Pluripotent Stem Cells: Tools for Advancing Diabetes Disease Modeling and Beta-Cell Development.
Millette K; Georgia S
Curr Diab Rep; 2017 Oct; 17(11):116. PubMed ID: 28980194
[TBL] [Abstract][Full Text] [Related]
2. CRISPR/Cas9 genome editing in human pluripotent stem cells: Harnessing human genetics in a dish.
González F
Dev Dyn; 2016 Jul; 245(7):788-806. PubMed ID: 27145095
[TBL] [Abstract][Full Text] [Related]
3. Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease.
Doetschman T; Georgieva T
Circ Res; 2017 Mar; 120(5):876-894. PubMed ID: 28254804
[TBL] [Abstract][Full Text] [Related]
4. CRISPR/Cas9 Genome Editing: A Promising Tool for Therapeutic Applications of Induced Pluripotent Stem Cells.
Zhang Y; Sastre D; Wang F
Curr Stem Cell Res Ther; 2018; 13(4):243-251. PubMed ID: 29446747
[TBL] [Abstract][Full Text] [Related]
5. A Scaled Framework for CRISPR Editing of Human Pluripotent Stem Cells to Study Psychiatric Disease.
Hazelbaker DZ; Beccard A; Bara AM; Dabkowski N; Messana A; Mazzucato P; Lam D; Manning D; Eggan K; Barrett LE
Stem Cell Reports; 2017 Oct; 9(4):1315-1327. PubMed ID: 29020615
[TBL] [Abstract][Full Text] [Related]
6. Genome Editing of Lineage Determinants in Human Pluripotent Stem Cells Reveals Mechanisms of Pancreatic Development and Diabetes.
Zhu Z; Li QV; Lee K; Rosen BP; González F; Soh CL; Huangfu D
Cell Stem Cell; 2016 Jun; 18(6):755-768. PubMed ID: 27133796
[TBL] [Abstract][Full Text] [Related]
7. Genome editing of human pancreatic beta cell models: problems, possibilities and outlook.
Balboa D; Prasad RB; Groop L; Otonkoski T
Diabetologia; 2019 Aug; 62(8):1329-1336. PubMed ID: 31161346
[TBL] [Abstract][Full Text] [Related]
8. A critical review on therapeutic approaches of CRISPR-Cas9 in diabetes mellitus.
Bora J; Dey A; Lyngdoh AR; Dhasmana A; Ranjan A; Kishore S; Rustagi S; Tuli HS; Chauhan A; Rath P; Malik S
Naunyn Schmiedebergs Arch Pharmacol; 2023 Dec; 396(12):3459-3481. PubMed ID: 37522916
[TBL] [Abstract][Full Text] [Related]
9. Genome engineering through CRISPR/Cas9 technology in the human germline and pluripotent stem cells.
Vassena R; Heindryckx B; Peco R; Pennings G; Raya A; Sermon K; Veiga A
Hum Reprod Update; 2016 Jun; 22(4):411-9. PubMed ID: 26932460
[TBL] [Abstract][Full Text] [Related]
10. Design and Validation of CRISPR/Cas9 Systems for Targeted Gene Modification in Induced Pluripotent Stem Cells.
Lee CM; Zhu H; Davis TH; Deshmukh H; Bao G
Methods Mol Biol; 2017; 1498():3-21. PubMed ID: 27709565
[TBL] [Abstract][Full Text] [Related]
11. Targeted Gene Editing in Human Pluripotent Stem Cells Using Site-Specific Nucleases.
Merkert S; Martin U
Adv Biochem Eng Biotechnol; 2018; 163():169-186. PubMed ID: 29124278
[TBL] [Abstract][Full Text] [Related]
12. Recent advances and potential applications of human pluripotent stem cell-derived pancreatic β cells.
Zhou Z; Ma X; Zhu S
Acta Biochim Biophys Sin (Shanghai); 2020 Jul; 52(7):708-715. PubMed ID: 32445468
[TBL] [Abstract][Full Text] [Related]
13. Highly Efficient CRISPR/Cas9-Mediated Genome Editing in Human Pluripotent Stem Cells.
Maguire JA; Gadue P; French DL
Curr Protoc; 2022 Nov; 2(11):e590. PubMed ID: 36426905
[TBL] [Abstract][Full Text] [Related]
14. Identifying Signalling Pathways Regulated by GPRC5B in β-Cells by CRISPR-Cas9-Mediated Genome Editing.
Atanes P; Ruz-Maldonado I; Hawkes R; Liu B; Persaud SJ; Amisten S
Cell Physiol Biochem; 2018; 45(2):656-666. PubMed ID: 29408822
[TBL] [Abstract][Full Text] [Related]
15. CRISPR/Cas9 Genome Engineering in Human Pluripotent Stem Cells for Modeling of Neurological Disorders.
Canals I; Ahlenius H
Methods Mol Biol; 2021; 2352():237-251. PubMed ID: 34324191
[TBL] [Abstract][Full Text] [Related]
16. Recent Advances in CRISPR/Cas9 Delivery Approaches for Therapeutic Gene Editing of Stem Cells.
Lotfi M; Morshedi Rad D; Mashhadi SS; Ashouri A; Mojarrad M; Mozaffari-Jovin S; Farrokhi S; Hashemi M; Lotfi M; Ebrahimi Warkiani M; Abbaszadegan MR
Stem Cell Rev Rep; 2023 Nov; 19(8):2576-2596. PubMed ID: 37723364
[TBL] [Abstract][Full Text] [Related]
17. CRISPR/Cas9: an advanced tool for editing plant genomes.
Samanta MK; Dey A; Gayen S
Transgenic Res; 2016 Oct; 25(5):561-73. PubMed ID: 27012546
[TBL] [Abstract][Full Text] [Related]
18. Highly Efficient CRISPR-Cas9-Mediated Genome Editing in Human Pluripotent Stem Cells.
Maguire JA; Cardenas-Diaz FL; Gadue P; French DL
Curr Protoc Stem Cell Biol; 2019 Feb; 48(1):e64. PubMed ID: 30358158
[TBL] [Abstract][Full Text] [Related]
19. CRISPR Genome Engineering for Human Pluripotent Stem Cell Research.
Chaterji S; Ahn EH; Kim DH
Theranostics; 2017; 7(18):4445-4469. PubMed ID: 29158838
[TBL] [Abstract][Full Text] [Related]
20. Application of CRISPR/Cas9 to human-induced pluripotent stem cells: from gene editing to drug discovery.
De Masi C; Spitalieri P; Murdocca M; Novelli G; Sangiuolo F
Hum Genomics; 2020 Jun; 14(1):25. PubMed ID: 32591003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
